Skip to main content
. 2013 Oct 2;24(4):321–329. doi: 10.3802/jgo.2013.24.4.321

Fig. 1.

Fig. 1

Kaplan-Meier estimates of postrecurrence survival according to the serum squamous cell carcinoma antigen (SCC-Ag) level. (A) Patients with serum SCC-Ag levels >2.0 ng/mL had a significantly shorter postrecurrence survival than those with serum SCC-Ag levels ≤2.0 ng/mL (p=0.033). (B) Patients with serum SCC-Ag levels ≥14.0 ng/mL also had a significantly shorter postrecurrence survival than those with serum SCC-Ag levels <14.0 ng/mL (p<0.001).